Source: BioPortfolio

Meda: Meda AB Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250

SummaryMeda AB Meda a subsidiary of Mylan NV is a specialty pharma company that develops manufactures and markets prescription and nonprescription drugs. The company offers products in categories of respiratory dermatology pain and inflammation Cx products...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Jörg-Thomas Dierks's photo - President & CEO of Meda AB

President & CEO

Jörg-Thomas Dierks

CEO Approval Rating

70/100

Read more